RAPT Therapeutics, Inc. (RAPT) Nonoperating Income (Expense) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
RAPT Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2024.
  • RAPT Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $2 M, a 12.8% decline year-over-year.
  • RAPT Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $9.97 M, a 153% increase year-over-year.
  • RAPT Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $10.3 M, a 424% increase from 2022.
  • RAPT Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.96 M, a 39040% increase from 2021.
  • RAPT Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $5 K, a 99.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $9.97 M $2 M -$294 K -12.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.3 M $2.34 M +$861 K +58.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $9.4 M $2.55 M +$2.11 M +475% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $7.3 M $3.08 M +$3.36 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $3.94 M $2.29 M +$1.98 M +641% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.96 M $1.48 M +$1.38 M +1310% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $582 K $443 K +$561 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $21 K -$275 K -$246 K -848% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $267 K $309 K +$262 K +557% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $5 K $105 K -$444 K -80.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $449 K -$118 K -$355 K -150% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $804 K -$29 K -$420 K -107% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.22 M $47 K -$88 K -65.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $1.31 M $549 K +$290 K +112% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.02 M $237 K -$107 K -31.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.13 M $391 K +$58 K +17.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $1.07 M $135 K -$221 K -62.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $1.29 M $259 K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $344 K +$83 K +31.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $333 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $356 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 $261 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.